An innovative biologic recycling process of leukoreduction filters to produce active human antimicrobial peptides
- 10 October 2013
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 54 (5) , 1332-1339
Abstract
Background: Human neutrophil peptides (HNPs) 1 to 3 are the major antimicrobial peptides of the azurophilic granules of neutrophils. They represent an important arm of the innate immune system. Their production by chemical synthesis and recombinant technologies is expensive and limited by technical constraints due to their composition and the presence of three disulfide bonds.Study Design and Methods: We have developed an original approach based on the purification of the natural human defensins HNPs 1 to 3 from neutrophils trapped on leukoreduction filters used in blood processing. The purification of HNPs 1 to 3 from these filters is performed in two steps: extraction of HNPs 1 to 3 retained in the filters followed by their immunoprecipitation. Studies were performed to determine the stability of defensins in the filters stored at room temperature. The activity of HNPs 1 to 3 obtained by our rapid protocol was validated by determining minimal inhibitory concentrations (MICs) against six reference bacterial strains and 12 clinical isolates.Results: The human defensins HNPs 1 to 3 extracted from leukoreduction filters displayed high antimicrobial activity against tested strains, with MIC values between 0.12 and 1 μg/mL. Kinetics assays showed the appearance of activity 15 minutes after peptide addition. Moreover, we found that the HNPs 1 to 3 purified from leukoreduction filters that had been stored for 45 days at room temperature remained active.Conclusion: Leukoreduction filters provide a rich and safe source of active human defensins HNPs 1 to 3. Moreover, the stability of the peptides in filters stored at room temperature allows envisaging a large‐scale development of the process.Keywords
This publication has 27 references indexed in Scilit:
- α‐Defensins in human innate immunityImmunological Reviews, 2011
- Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicinEuropean Journal of Clinical Microbiology & Infectious Diseases, 2011
- The expanding scope of antimicrobial peptide structures and their modes of actionTrends in Biotechnology, 2011
- Multifunctional cationic host defence peptides and their clinical applicationsCellular and Molecular Life Sciences, 2011
- Antimicrobial peptides: General overview and clinical implications in human health and diseaseClinical Immunology, 2010
- Human Defensins: Synthesis and Structural PropertiesCurrent Pharmaceutical Design, 2007
- Defensins in innate antiviral immunityNature Reviews Immunology, 2006
- Defensins: antimicrobial peptides of innate immunityNature Reviews Immunology, 2003
- Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity.Journal of Clinical Investigation, 1989
- Defensins. Natural peptide antibiotics of human neutrophils.Journal of Clinical Investigation, 1985